Centre for Addiction and Mental Health — CureCurrent

How to interpret these research links

Connected source records

The exact organization name Centre for Addiction and Mental Health appears in 165 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials165

Recruiting shown16

Roles2

SourceClinicalTrials.gov

Clinical trials

60 shown

Theta-Burst Stimulation to Treat DepressionNCT07033780 · lead sponsor · 2025-06-01

Magnetic Seizure Therapy for Schizophrenia - TrialNCT06672588 · lead sponsor · 2025-04-22

Accelerated vs. Conventional Theta Burst Stimulation for Late-life DepressionNCT06854367 · lead sponsor · 2025-03-27

Validating the On-line Creyos Cognitive Assessment Platform in Older Adults With Major Depressive Disorder or Mild Cognitive ImpairmentNCT06780917 · lead sponsor · 2025-01-13

Nature-based Virtual Reality Intervention for Depression in Alzheimer's DiseaseNCT06732128 · lead sponsor · 2025-01-06

TACS to Engage Theta-Gamma Coupling and Enhance Working Memory in Patients With MCI (tACS-MCI)NCT06783283 · lead sponsor · 2025-01-02

Technology-Enabled Collaborative Care for Young Adults With Type 1 Diabetes and Diabetes Distress: A Feasibility TrialNCT06804694 · lead sponsor · 2024-11-27

Presynaptic Imaging in Major Depressive Episodes After COVID-19NCT06086366 · lead sponsor · 2023-08-22

Metformin for Antipsychotic-induced Weight Gain in Adults With Intellectual DisabilityNCT05744479 · lead sponsor · 2023-02-28

Effects of NAC on Symptoms of CHR PatientsNCT05142735 · lead sponsor · 2023-01-13

E-field Guided iTBS for Treatment Resistant DepressionNCT05583747 · lead sponsor · 2022-10-24

"Extended" (Alternate Day) Antipsychotic DosingNCT04478838 · lead sponsor · 2022-06-06

Effectiveness of an Integrated Care Pathway for Depression: Cluster Randomized Controlled TrialNCT05142683 · lead sponsor · 2022-02-01

Extended Effects of Cannabis Abstinence on Clinical Symptoms and Cognition in DepressionNCT04935619 · lead sponsor · 2021-07-21

rTMS for Depression in Young Adults With AutismNCT04972136 · lead sponsor · 2021-01-14

Switching From Twice-Daily to Once-Daily Clozapine Dosing in SchizophreniaNCT02639702 · lead sponsor · 2016-10-15

Group Dialectical Behaviour Therapy (DBT) Skills Training for First Episode PsychosisNCT07777315 · lead sponsor · 2026-09-15

NOT_YET_RECRUITING

Identifying Biomarkers of Response to Digital Interventions for Mood DisordersNCT07783633 · lead sponsor · 2026-07-28

ENROLLING_BY_INVITATION

Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use DisorderNCT07405606 · lead sponsor · 2026-03-01

NOT_YET_RECRUITING

Effects of Antipsychotics on Brain Insulin Action in FemalesNCT06251635 · lead sponsor · 2024-06-03

ACTIVE_NOT_RECRUITING

Investigating the Muscarinic System in Schizophrenia Using Positron Emission TomographyNCT06278246 · lead sponsor · 2024-03-11

ACTIVE_NOT_RECRUITING

Racial Disparities in Antidepressant Treatment After a Psychiatric ConsultationNCT06799078 · lead sponsor · 2024-03-04

ACTIVE_NOT_RECRUITING

The Effects of Non-invasive Neuromodulation on Illness Awareness in SchizophreniaNCT05957484 · lead sponsor · 2023-09-12

Optimizing Mental Health for Young People at Clinical High Risk for Psychosis (CHR)NCT05757128 · lead sponsor · 2023-08-24

Does Abnormal Insulin Action in the Brain Underlie Cognitive and Metabolic Dysfunction in SchizophreniaNCT05748990 · lead sponsor · 2023-04-01

ACTIVE_NOT_RECRUITING

Risk of Breakthrough Symptoms With Long-Acting Injectable MedicationsNCT05473741 · lead sponsor · 2023-01-11

A Remote Electronically Delivered Integrated Care Pathway: A Feasibility StudyNCT05086120 · lead sponsor · 2023-01-04

Microglial Activation in Inflammatory Bowel DiseaseNCT03487926 · lead sponsor · 2022-09-14

Semaglutide in Comorbid Schizophrenia Spectrum Disorder and ObesityNCT05333003 · lead sponsor · 2022-05-25

ACTIVE_NOT_RECRUITING

rTMS for Suicidality in Opioid Use DisorderNCT04785456 · lead sponsor · 2022-03-01

Community Reinforcement Approach and Family Training for Substance Use in Early Psychosis InterventionNCT05300633 · lead sponsor · 2022-02-08

Cognitive Dysfunction in the Addictions Study - Project 4 (P4)NCT06299787 · lead sponsor · 2022-02-07

PrEP and Alcohol - Enhancing HIV Pre-Exposure Prophylaxis (PrEP)NCT05097430 · lead sponsor · 2021-09-28

Does tDCS Change Synaptic Density in the Brains of Patients With SchizophreniaNCT05435300 · lead sponsor · 2021-09-17

ACTIVE_NOT_RECRUITING

A Pilot Trial of Nabilone for the Treatment of ObesityNCT04801641 · lead sponsor · 2021-09-17

Is Brain Insulin Resistance a Feature of the Biology of Depression in AdolescentsNCT05571878 · lead sponsor · 2021-09-01

Neuroinflammation in COVID-19 and DepressionNCT04854785 · lead sponsor · 2021-06-14

Technology-enabled Collaborative Care for Diabetes Management During COVID-19NCT04607915 · lead sponsor · 2021-05-04

MAO-B Occupancy in Depressed PatientsNCT04841798 · lead sponsor · 2021-04-15

Brief Digital CBT for Mood and Anxiety Symptoms in Acute Psychiatric InpatientsNCT04841603 · lead sponsor · 2021-04-12

Examining a Digital Health Approach for Advancing Schizophrenia Illness Self-management and Provider EngagementNCT04602741 · lead sponsor · 2021-01-04

Non-Inferiority RCT Comparing Online and On-Site CBT in MDDiNCT04825535 · lead sponsor · 2020-12-15

Neuromodulation of Social Cognitive Circuitry in People With Schizophrenia Spectrum DisordersNCT04418011 · lead sponsor · 2020-11-30

ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis InterventionNCT04298450 · lead sponsor · 2020-09-21

Accelerated iTBS for Depressed Patients During the COVID-19 PandemicNCT04384965 · lead sponsor · 2020-05-12

High Dose Accelerated iTBS for DepressionNCT04255784 · lead sponsor · 2020-02-06

Early Psychosis Intervention - Spreading Evidence-based TreatmentNCT03919760 · lead sponsor · 2020-01-03

A Study of Cognitive Adaptation Training in Inpatient Forensic EnvironmentsNCT04294719 · lead sponsor · 2019-12-12

The Effects of Non-invasive Brain Stimulation on Treatment Adherence in SchizophreniaNCT04033679 · lead sponsor · 2019-08-15

ACTIVE_NOT_RECRUITING

RCT of Brain Longitudinal Biomarker Study (OPT-Neuro RCT)NCT05531591 · lead sponsor · 2019-08-01

Targeting Brain Physiology to Treat Neuropsychiatric Symptoms of Dementia Using TMS-EEG and tDCSNCT03846492 · lead sponsor · 2019-04-24

ACTIVE_NOT_RECRUITING

Online Writing Intervention for Major Depressive DisorderNCT06699719 · lead sponsor · 2019-03-27

Reactivity of the Vestibular System to Caloric Vestibular Stimulation in SchizophreniaNCT03048370 · lead sponsor · 2019-01-01

Standardizing Care for Neuropsychiatric Symptoms and Quality of Life in DementiaNCT03672201 · lead sponsor · 2018-11-01

ACTIVE_NOT_RECRUITING

Cognitive Remediation Therapy for Participants With Late-Life SchizophreniaNCT03695614 · lead sponsor · 2018-10-24

Efficacy of Convulsive Therapies During ContinuationNCT03711019 · lead sponsor · 2018-10-22

Maintenance of Response After rTMS for Depression Using tDCSNCT03708159 · lead sponsor · 2018-09-24

Technology-Enabled Collaborative Care for YouthNCT03610087 · lead sponsor · 2018-07-25

MARt-Depression TrialNCT03564067 · lead sponsor · 2018-07-05

Non-invasive Brain Stimulation Using Transcranial Direct Current Stimulation for Neuropsychiatric Symptoms of DementiaNCT03638284 · lead sponsor · 2018-07-05

Sponsor roles

lead sponsor131

collaborator34

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.